2021: Expiring drug patents

 

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.

Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.

This chart shows which pharmaceutical companies face the most patent expirations this year.

 

The drug companies facing the most patent expirations this year are:

Novartis

Alexza Pharms

Allergan

Sunovion

Cumberland Pharms

Gilead Sciences Inc

Alnylam Pharms Inc

Astrazeneca

Bayer Hlthcare

Gilead